Abstract:We read with great interest the article by Meng et al.1 regarding the anti-epithelial-mesenchymal transition (EMT) and antitumor metastasis effects of a histamine receptor ligand, clobenpropit, on human cholangiocarcinoma (CCA) both in vitro and in vivo. In this well-performed study the authors provided evidence that clobenpropit significantly decreased CCA proliferation by way of a Ca2+-dependent pathway and altered morphological development and invasion in vitro, which effects became greater after H3 histamine receptors (H3HRs) knockdown or overexpression of H4 histamine receptors (H4HRs). The authors hence attributed these effects of clobenpropit to primary H4HR-mediated effects. We agree with the authors that clobenpropit is a specific H3 antagonist / H4 agonist and appreciate the efforts that the authors made to exclude the involvement of H3HRs in vitro. However, some statements mentioned by the authors may be inaccurate and the in vivo evidence may be insufficient to some extent, which made their conclusion less persuasive. The authors demonstrated in the Discussion that clobenpropit stimulated H4HRs at a much higher affinity compared with H3HRs according to one reference (see reference 28 in the article). On the contrary, according to the comprehensive information from the International Union of Pharmacology (IUPHAR) receptor database,2 the affinity of clobenpropit for human H3HRs (pKi value: 8.4-9.4) is much higher than that for human H4HRs (pKi value: 7.4-8.3). Furthermore, the authors showed that, after H3HR knockdown, clobenpropit decreased CCA proliferation to a greater extent than in cells with H3HR expression, which we believe should not be interpreted as that H3HRs were not involved but logically indicates that H3HRs did play certain roles in CCA proliferation in this in vitro system. Decreased expression of H3HRs will obviously result in loss of a blocking effect of their antagonism. Therefore, the blocking effect of clobenpropit on H3HRs should not be neglected, especially in vivo, when the endogenous natural agonist, histamine, widely exists. However, the in vivo experiments of this study did not exclude the possible involvement of H3HRs. Therefore, we feel that more evidence (obtained based on either pharmacological methods or transgenic animal models) should be provided before any conclusion can be drawn about which receptors (H3HRs or H4HRs) are really involved in suppressing human CCA progression. Gong-Hao He M.D., Ph.D.*, Gui-Li Xu Ph.D.*, Wen-Ke Cai M.D., Ph.D.*, Wei Xia M.Sc.*, * Kunming General Hospital of Chengdu Military Region, Kunming, Yunnan, China.

Activation of histamine H4 receptor suppresses the proliferation and invasion of esophageal squamous cell carcinoma via both metabolism and non-metabolism signaling pathways

Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity

Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma.

Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer

Claudin-1/4 as directly target gene of HIF-1α can feedback regulating HIF-1α by PI3K-AKT-mTOR and impact the proliferation of esophageal squamous cell though Rho GTPase and p-JNK pathway

Integrative Analysis of Histone Acetylation Regulated CYP4F12 in Esophageal Cancer Development

HDAC2 Regulates Cell Proliferation, Cell Cycle Progression and Cell Apoptosis in Esophageal Squamous Cell Carcinoma EC9706 Cells

PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways

HMGA1 promotes the progression of esophageal squamous cell carcinoma by elevating TKT-mediated upregulation of pentose phosphate pathway

The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma

KHK-A Promotes the Proliferation of Oesophageal Squamous Cell Carcinoma Through the Up-Regulation of PRPS1.

Upregulation of the Long Non-Coding Rna Hotair Promotes Esophageal Squamous Cell Carcinoma Metastasis and Poor Prognosis

Elevated Serine Protease Htra1 Inhibits Cell Proliferation, Reduces Invasion, And Induces Apoptosis In Esophageal Squamous Cell Carcinoma By Blocking The Nuclear Factor-Kappa B Signaling Pathway

RSK4 Promotes the Macrophage Recruitment and M2 Polarization in Esophageal Squamous Cell Carcinoma.

High Level of H3K4 Tri-Methylation Modification Predicts Poor Prognosis in Esophageal Cancer

HOXC6 Promotes Migration, Invasion and Proliferation of Esophageal Squamous Cell Carcinoma Cells Via Modulating Expression of Genes Involved in Malignant Phenotypes

Upregulation of Histamine Receptor H1 Promotes Tumor Progression and Contributes to Poor Prognosis in Hepatocellular Carcinoma

Activation of endoplasmic reticulum stress by harmine suppresses the growth of esophageal squamous cell carcinoma

Increased Expression of EHF Via Gene Amplification Contributes to the Activation of HER Family Signaling and Associates with Poor Survival in Gastric Cancer

Effect of H3K27 Acetylation Activated-Long Noncoding RNA CCAT1 on Cell Proliferation and Migration by Regulating SPRY4 and HOXB13 Expression in Esophageal Squamous Carcinoma Cell.

H3 or H4 Histamine Receptors: That Which Contributes to Suppressing Human Cholangiocarcinoma Progression Still Remains to Be Clarified